157 related articles for article (PubMed ID: 23479446)
1. Notch receptors in human choroid plexus tumors.
Beschorner R; Waidelich J; Trautmann K; Psaras T; Schittenhelm J
Histol Histopathol; 2013 Aug; 28(8):1055-63. PubMed ID: 23479446
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin receptor expression in normal and neoplastic choroid plexus.
Beschorner R; Psaras T; Meyermann R; Bremer J; Schmidt T; Mittelbronn M; Schittenhelm J
Clin Neuropathol; 2011; 30(1):33-40. PubMed ID: 21176716
[TBL] [Abstract][Full Text] [Related]
3. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
[TBL] [Abstract][Full Text] [Related]
4. Notch3 signaling initiates choroid plexus tumor formation.
Dang L; Fan X; Chaudhry A; Wang M; Gaiano N; Eberhart CG
Oncogene; 2006 Jan; 25(3):487-91. PubMed ID: 16186803
[TBL] [Abstract][Full Text] [Related]
5. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
Beschorner R; Pantazis G; Jeibmann A; Boy J; Meyermann R; Mittelbronn M; Schittenhelm J
Acta Neuropathol; 2009 Jun; 117(6):667-75. PubMed ID: 19283393
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of CDX2 expression in normal choroid plexus epithelium and choroid plexus tumors.
Beschorner R; Mittelbronn M; Mugler M; Meyermann R; Schittenhelm J
Histol Histopathol; 2009 Dec; 24(12):1507-14. PubMed ID: 19795349
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of Notch receptors in human hepatocellular carcinoma.
Gao J; Song Z; Chen Y; Xia L; Wang J; Fan R; Du R; Zhang F; Hong L; Song J; Zou X; Xu H; Zheng G; Liu J; Fan D
Dig Liver Dis; 2008 Feb; 40(2):114-21. PubMed ID: 17920003
[TBL] [Abstract][Full Text] [Related]
9. P53 expression in choroid plexus neoplasms: an immunohistochemical study.
Jay V; Ho M; Chan F; Malkin D
Arch Pathol Lab Med; 1996 Nov; 120(11):1061-5. PubMed ID: 12049110
[TBL] [Abstract][Full Text] [Related]
10. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
11. Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups.
Thomas C; Sill M; Ruland V; Witten A; Hartung S; Kordes U; Jeibmann A; Beschorner R; Keyvani K; Bergmann M; Mittelbronn M; Pietsch T; Felsberg J; Monoranu CM; Varlet P; Hauser P; Olar A; Grundy RG; Wolff JE; Korshunov A; Jones DT; Bewerunge-Hudler M; Hovestadt V; von Deimling A; Pfister SM; Paulus W; Capper D; Hasselblatt M
Neuro Oncol; 2016 Jun; 18(6):790-6. PubMed ID: 26826203
[TBL] [Abstract][Full Text] [Related]
12. Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience.
Bahar M; Hashem H; Tekautz T; Worley S; Tang A; de Blank P; Wolff J
J Neurooncol; 2017 May; 132(3):427-432. PubMed ID: 28290001
[TBL] [Abstract][Full Text] [Related]
13. Aberrant E-cadherin, β-catenin, and glial fibrillary acidic protein (GFAP) expression in canine choroid plexus tumors.
Nentwig A; Higgins RJ; Francey T; Doherr M; Zurbriggen A; Oevermann A
J Vet Diagn Invest; 2012 Jan; 24(1):14-22. PubMed ID: 22362931
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
Ikota H; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
[TBL] [Abstract][Full Text] [Related]
15. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner.
Pierfelice TJ; Schreck KC; Dang L; Asnaghi L; Gaiano N; Eberhart CG
Cancer Res; 2011 Feb; 71(3):1115-25. PubMed ID: 21245095
[TBL] [Abstract][Full Text] [Related]
16. Atypical teratoid/rhabdoid tumors may show morphological and immunohistochemical features seen in choroid plexus tumors.
Schittenhelm J; Nagel C; Meyermann R; Beschorner R
Neuropathology; 2011 Oct; 31(5):461-7. PubMed ID: 21276081
[TBL] [Abstract][Full Text] [Related]
17. The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus.
Varga Z; Vajtai I; Aguzzi A
Pathol Res Pract; 1996 Dec; 192(12):1225-31. PubMed ID: 9182293
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
Albrecht S; Rouah E; Becker LE; Bruner J
Mod Pathol; 1991 Sep; 4(5):610-4. PubMed ID: 1758873
[TBL] [Abstract][Full Text] [Related]
19. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors.
Wrede B; Liu P; Wolff JE
J Neurooncol; 2007 Dec; 85(3):345-51. PubMed ID: 17576522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
